Navidea生物制药(NAVB)

LAES1682021-02-23 01:34

$Navidea生物制药(NAVB)$ 上车查看全文

LAES1682021-02-05 00:41

$Navidea生物制药(NAVB)$ 上车了查看全文

兔斯基不吃面2020-05-22 20:26

$Navidea生物制药(NAVB)$ 下一个轮到ABUS生物制药哈哈哈，异曲同工查看全文

南無哈利路亚2020-05-22 18:12

$Navidea生物制药(NAVB)$ 今天看你查看全文

荣耀之战2020-05-22 06:41

$Navidea生物制药(NAVB)$ 盘后什么消息了？查看全文

小水大雨2019-12-31 01:40

$Navidea生物制药(NAVB)$ 未来几天， 估计持续上涨的机率比较大。 但是交易量很低的小盘股， 知适合很小的资金投机一下。 买了200股， 试试运气查看全文

用户48783635432019-04-09 14:29

【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验，此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈，宣布重启对NAV3-31的2b期临床试验计划，评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文

鹰眼20072019-04-08 19:54

$Navidea生物制药(NAVB)$ wow查看全文

鹰眼20072019-03-24 13:10

$Navidea生物制药(NAVB)$ 查看全文

艾萨克的猫2018-10-23 23:00

$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-08-31 AccNo: 0001144204-16-122195 Size: 16 KBItem 7.01: Regulation FD Disclosure 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-08-11 AccNo: 0001564590-16-024057 Size: 7 MB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-08-11 AccNo: 0001144204-16-118413 Size: 79 KBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2016-08-10 AccNo: 0001144204-16-118008 Size: 31 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-08-04 AccNo: 0001144204-16-116406 Size: 174 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 美东时间 2016-08-04 09:00 Before Open:NAVIDEA BIOPHAR Earning Release 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-07-18 AccNo: 0001144204-16-113375 Size: 17 KBItem 7.01: Regulation FD Disclosure 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-07-01 AccNo: 0001144204-16-111085 Size: 290 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ DEF 14A - Other definitive proxy statements Filed: 2016-07-01 AccNo: 0001144204-16-111082 Size: 564 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-06-28 AccNo: 0001299265-16-000008 Size: 136 KB 网页链接